Sajile, Fatima Romaisa S.

HRN: 27-85-76  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2025
CEFUROXIME 750MG (VIAL)
09/25/2025
10/08/2025
IV
440mg
Q8
Open Fracture
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines